Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

NEW
FRA:DUL (USA)   Ordinary Shares
€ 235.9 +2.5 (+1.07%) Jul 23
73.43
P/B:
33.35
Market Cap:
€ 31.44B ($ 35.79B)
Enterprise V:
€ 29.92B ($ 34.06B)
Volume:
14.00
Avg Vol (2M):
142.00
Trade In:

Alnylam Pharmaceuticals Inc (FRA:DUL) Dividend

Alnylam Pharmaceuticals Inc (FRA:DUL) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:DUL Dividend

Does Alnylam Pharmaceuticals Inc (FRA:DUL) pay a dividend?

Alnylam Pharmaceuticals Inc (FRA:DUL) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Alnylam Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Alnylam Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -2.2% over the past 3 years.

What are dividend-paying alternatives to Alnylam Pharmaceuticals Inc?

For dividend-paying alternatives in Alnylam Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.